The 2021 Medtech Contract Manufacturing Report

innovation hub

Capnia (NASDAQ:CAPN) is Profiled in this Database

Updated At 05 May, 2011

Start Free 7 Day Trial Now
Partial description of this company
A handheld device for the as-needed treatment of allergic rhinitis

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Capnia (NASDAQ:CAPN) plus 4856 other startups.

Start Free 7 Day Trial Now

Learn More About Capnia (NASDAQ:CAPN)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation


Our Clients